News | January 23, 2013

Ablation Devices to Be the Fastest Growing Segment in the U.S. Nonvascular Interventional Radiology Device Market

Overall market to grow moderately to $295 million by 2017, according to Millennium Research Group

January 23, 2013 — According to Millennium Research Group (MRG), the segment of the U.S. nonvascular interventional radiology device market with the fastest growth and greatest potential is ablation devices, comprising radiofrequency (RF) ablation, cryoablation and microwave ablation devices. The overall market will grow moderately to $295 million by 2017.

Ablation devices offer a minimally invasive alternative to traditional surgical treatment of liver, prostate, kidney and lung cancers, and this segment is growing quickly because of the increasing popularity of minimally invasive treatments and the rising incidence of these soft tissue cancers.

RF ablation is the most established device type, but microwave ablation and cryoablation are growing rapidly, due to some advantages these types of ablation offer. Microwave ablation devices can produce larger ablation zones and don’t suffer as much from the heat sink effect that can handicap RF ablation. Growth in microwave ablation devices has stalled growth in RF ablation, and this segment of the market will slightly decline through 2017.

Microwave ablation devices are currently sold mainly by smaller companies with limited distribution networks. This has made them attractive acquisition targets by more established companies. For example, AngioDynamics, a leader in RF ablation, recently made a large investment in Microsulis, a microwave ablation company.

Cryoablation devices are the only kind of ablation device that can be used to treat prostate cancer. Urologists and interventional radiologists both use cryoablation to treat kidney cancer, using differing techniques.

“Cryoablation is more versatile than other ablation devices because its effects do not need to be permanent,” said MRG Analyst Sean Messenger. “As a result, it can be useful in indications outside of cancer, most prominently in pain palliation, another growing market. Competitors see the opportunity for significant growth, leading Endo Health Solutions, a company with a large pain franchise and a focus on pain palliation, to acquire the top cryoablation manufacturer, HealthTronics, in 2010.”

Millennium Research Group’s U.S. Markets for Nonvascular Interventional Radiology Devices 2013 report includes unit, installed base, average selling price and revenue information, along with market drivers and limiters and competitive landscape for ablation devices, percutaneous drainage catheters and soft tissue biopsy needles in the United States.

For more information: www.MRG.net, www.DecisionResourcesGroup.com

Related Content

Image courtesy of Philips

Image courtesy of Philips

Feature | Interventional Radiology | July 05, 2018 | By Jeff Zagoudis
On May 14, 2018, First Lady Melania Trump underwent an embolization procedure for what was called a benign kidney...
Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter
Technology | Interventional Radiology | June 29, 2018
Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation...
Guerbet Launches Pair of Microcatheters for Interventional Radiology Procedures
Technology | Interventional Radiology | May 23, 2018
Guerbet LLC USA announced the upcoming launch of SeQure and DraKon, two novel microcatheters for tumor and vascular...
Melania Trump in hospital to undergo an interventional radiology (IR) catheter embolization procedure in her kidneys. Angiogram of a kidney.

First Lady Melania Trump in hospital to undergo an interventional radiology (IR) catheter embolization procedure in her kidneys. The left image is an example of a kidney angiogram to highlight the renal blood vessels during an interventional procedure.

News | Interventional Radiology | May 15, 2018 | Dave Fornell
May 15, 2018 — U.S.
Capitol Hill Briefing Explores Role of Interventional Radiology in Healthcare
News | Interventional Radiology | May 09, 2018
The Society of Interventional Radiology (SIR), in conjunction with Rep. Mia Love (R-Utah) participated in a panel...
Body Vision Medical Receives FDA Clearance for LungVision Tool
Technology | Lung Cancer | May 09, 2018
Body Vision Medical received clearance from the U.S. Food and Drug Administration (FDA) to market their LungVision Tool...
360 View of a Cath Lab at Northwestern Medicine Central DuPage Hospital
360 Photos | Angiography | May 03, 2018
A 360 degree view of the newest cath lab at...
El Camino Hospital Performs First U.S. Robotic Lung Cancer Bronchoscopy
News | Oncology Diagnostics | April 25, 2018
The interventional pulmonology team at the Taft Center for Clinical Research at El Camino Hospital in Mountain View,...
GE's OEC Elite CFD

GE's OEC Elite CFD

Feature | Mobile C-Arms | April 18, 2018 | Jeff Zagoudis
The market for mobile C-arm techn...
Medical Societies Issue Revised, Patient-Centered Measures for Stroke Interventions
News | Stroke | April 02, 2018
Revised guidelines for the nonsurgical, image-guided interventional treatment of acute ischemic stroke will ensure...